Acquiring Company
EVERSANA
Acquired Company
Estima Scientific
Chicago
Greater LondonSecurityCyber SecurityBiotechnologyHealth CareArtificial IntelligencePharmaceuticalDescription
EVERSANA announced the acquisition of London-based Estima Scientific, an AI and automation HEOR technology and services company. Estima's consulting expertise and proprietary software will be integrated into EVERSANA's market access and value and evidence solutions. Estima's co-founders Tim Reason and Andy Gimblett will join EVERSANA's global workforce. Financial terms were not disclosed.
Who to call at EVERSANA, and when
When EVERSANA changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day EVERSANA raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at EVERSANA, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at EVERSANA. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment EVERSANA makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Estima Scientific?
Estima Scientific was acquired by EVERSANA, based in Chicago. The deal was reported on October 28, 2026. This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. EVERSANA is privately held and operates in Security.
When did EVERSANA acquire Estima Scientific?
EVERSANA's acquisition of Estima Scientific was reported on October 28, 2026. EVERSANA announced the acquisition of London-based Estima Scientific, an AI and automation HEOR technology and services company. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Estima Scientific do?
Estima Scientific is a London-based health economics and outcomes research (HEOR) technology and services company. It combines specialist consulting with proprietary, AI-powered software. It is privately held, operating in Biotechnology, and is based in Greater London.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.